Latest Indonesia News

PT ANTAM has raised its 2025 cash dividend by 38%, distributing Rp5.05 trillion to shareholders, reflecting strong profitability and a sustained commitment to shareholder returns.

Bass Oil reported a 3% production increase in June 2026, driven by Indonesian output and Cooper Basin gains. The Bunian 6 well drilling is underway, expected to double group production, while the Vanessa gas field acquisition opens new gas sales and commercialisation pathways.

Loyal Metals has sent its Scheme Booklet to shareholders detailing the proposed A$0.45 per share acquisition by PT Bumi Resources, setting the stage for a shareholder vote on 20 August 2026.

BPH Global has kicked off direct seaweed exports to China, reporting AUD 535,895 in sales for the latest trading period and expanding its footprint beyond Indonesia.

ReNerve has locked in a flexible A$5 million convertible note facility with RiverFort, drawing an initial A$1.6 million to back its commercial push and US sales ramp-up.

Foresta Group Holdings has received allowance from the USPTO for its US patent application covering its proprietary rosin and terpene production process, expected to protect its technology until at least 2041.

ReNerve Limited has secured regulatory approval to market its flagship NervAlign Nerve Cuff in Indonesia, marking a major step in its Asia-Pacific expansion and unlocking access to one of the region’s largest nerve repair markets.

TruScreen Group posted a NZ$2.25 million loss for FY2026, with its auditor highlighting material uncertainty over the company’s ability to continue without further funding. Revenue rose to NZ$2.4 million amid geographic expansion, but cash burn and accumulated losses remain significant.

Recce Pharmaceuticals secured A$4 million through an institutional placement and launched a Share Purchase Plan to raise up to an additional A$4 million, bolstering funds for commercial licensing and ongoing clinical programs.

Nickel Industries is investing US$169 million for a 17.5% stake in the PT Teluk Metal Industry HPAL project, aiming for production by September 2027 and leveraging its exclusive ore supply from Sampala.

Recce Pharmaceuticals has secured ethics approval to upgrade and broaden its pivotal Phase 3 trial of RECCE® 327 Topical Gel for diabetic foot infections in Australia, accelerating recruitment and reinforcing its global registration ambitions.

Far East Gold has increased its ownership of the high-grade Idenburg Gold Project in Indonesia to 51%, issuing $6.5 million in shares to vendors and setting sights on an 80% stake after feasibility study approval.